Next Article in Journal
Reusable SERS Platform of Femtosecond Laser Processed Substrate for Detection of Malachite Green
Next Article in Special Issue
Efficient Biotransformation of Icariin to Baohuoside I Using Two Novel GH1 β-Glucosidases
Previous Article in Journal
Preparation of Composites Derived from Modified Loess/Chitosan and Its Adsorption Performance for Methyl Orange
Previous Article in Special Issue
Bioactive Compounds Produced by Endophytic Bacteria and Their Plant Hosts—An Insight into the World of Chosen Herbaceous Ruderal Plants in Central Europe
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Synthesis of Natural Products Using Engineered Plants and Microorganisms

by
Yongjun Wei
1,2,*,
Lingbo Qu
2,* and
Xiaojun Ji
3,*
1
School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China
2
Zhengzhou Research Base, State Key Laboratory of Cotton Bio-Breeding and Integrated Utilization, Laboratory of Synthetic Biology, Zhengzhou University, Zhengzhou 450001, China
3
State Key Laboratory of Materials-Oriented Chemical Engineering, College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing 211816, China
*
Authors to whom correspondence should be addressed.
Molecules 2024, 29(21), 5054; https://doi.org/10.3390/molecules29215054
Submission received: 11 October 2024 / Accepted: 18 October 2024 / Published: 26 October 2024
Microorganisms and plants, particularly medicinal herbs, are abundant sources of diverse natural products, many of which are bioactive molecules with significant pharmaceutical or health benefits, and include artemisinin [1,2], ginsenosides [3], and Ganoderic triterpenes [4]. However, the contents of these bioactive compounds in their natural sources are often low [5]. The advancement of omics technologies and synthetic biology has opened new avenues for producing these valuable molecules through metabolically engineered plants and microorganisms [6]. Notable examples include the scaled-up production of artemisinin, rare ginsenosides, and various other natural products, which have potential applications in drugs, cosmetics, functional foods, animal feed, and other health-related products [7]. There is growing interest in utilizing cutting-edge synthetic biology technologies to further enhance the utilization of these natural products through the engineering of both plants and microorganisms [8].
This Special Issue is a collection of relevant research articles and reviews that highlight recent advancements in the production of bioactive natural products using engineered plants or microorganisms. Zhao, et al. summarized the artemisinin biosynthesis pathway, discussed advances in heterologous production using Escherichia coli and Saccharomyces cerevisiae, and explored metabolic engineering strategies in Artemisia annua and other plants to enhance artemisinin yields [9]. Zhang, et al. examined the pharmacological activities, biosynthesis pathways, extraction methods, and advances in the biotransformation and microbial synthesis of Epimedium flavonoids. Moreover, they discussed strategies to boost the industrial-scale production and utilization of Epimedium flavonoids [10]. Xu, et al. described the extraction, content determination, bioactivities, and product development of Lycium ruthenicum Murray’s bioactive substances, and discussed their potential medicinal and economic value [11]. Drożdżyński, et al. explored how plants and their endophytes adapt to harsh environments, focusing on the bioactive metabolites produced by them in synanthropic ruderal plants for potential use in agriculture and medicine [12]. Su, et al., using transcriptome and metabolome tools, revealed that the adaptation of Citrus reticulata ‘Chachi’ to a saline environment enhanced its high production of naringin and narirutin [13].
The function of bioactive natural products in plants and microorganisms are discussed in this Special Issue. Ma, et al. investigated the triterpenoids and ergostane steroids in Ganoderma luteomarginatum, which is distributed in Hainan province, China, and their evaluation of several natural products indicated that certain natural products displayed potential anti-tumor effects [14]. Alanazi, et al. found that Syzygium aromaticum (clove) oil had the ability to inhibit methicillin-resistant Staphylococcus aureus infection [15]. Sun, et al. identified and evaluated the anti-inflammatory constituents in Ardisiae Japonicae Herba (AJH) extracts, and found that ethyl acetate extract (EA) displayed significant anti-inflammatory activity and contained key pharmacodynamic components like bergenin, quercetin, and epigallocatechingallate, crucial for treating acute lung injury (ALI) [16]. Zhang, et al. found that ginsenoside Rb1, compound K, and 20(S)-protopanaxadiol had the ability to attenuate high-fat-diet-induced hyperlipidemia in rats by modulating the gut microbiota and bile acid metabolism [17].
Sun, et al. successfully increased the yield of 1,4-diaminobutane to 272 mg/L from engineered E. coli via the optimization of the synthesis of the cofactors PLP and NADPH [18]. Caballero Cerbon, et al. highlighted that eliminating L-cysteine desulfhydrases is key to improving L-cysteine production in engineered microbes, and outlined several strategies to tackle this issue [19]. Li, et al. demonstrated that biological nano selenium (SeNPs) and sodium selenite (Na2SeO3) treatments enhanced the organic selenium content in cowpea pods, and identified that a certain ABC transporter family played a crucial role in selenium absorption and transport [20]. Tu, et al. isolated Klebsiella aerogenes TL3 from termite guts, and demonstrated that it could degrade lignin anaerobically through a novel mechanism involving C-O and C-C bond cleavage, side chain oxidation, demethylation, and aromatic ring destruction [21].
Despite significant achievements in the synthesis of natural products using engineered plants and microorganisms, many bioactive natural products remain undeveloped [22]. Therefore, it is essential to leverage interdisciplinary tools, such as synthetic biology and engineering biology, to promote the development of related industries [23]. Through close collaboration between academia and industry, it is anticipated that a greater number of bioactive natural products could be discovered and utilized via engineered plants and microorganisms, thereby promoting technological innovation and market expansion in related industries.

Author Contributions

Conceptualization, Y.W., L.Q. and X.J.; writing—original draft preparation, Y.W.; writing—review and editing, L.Q. and X.J. All authors have read and agreed to the published version of the manuscript.

Funding

This study was supported by the National Natural Science Foundation of China (No. 32371485 and 32111530179), Henan Province Outstanding Youth Foundation (No. 242300421097), Muyuan Laboratory (No. 12106022401), Zhengzhou Research Base, National Key Laboratory of Cotton Bio-breeding and Integrated Utilization (No. CBIU2024002 and CB2024A30), and the State Key Laboratory of Materials-Oriented Chemical Engineering (No. SKL-MCE-23B04).

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Ro, D.K.; Paradise, E.M.; Ouellet, M.; Fisher, K.J.; Newman, K.L.; Ndungu, J.M.; Ho, K.A.; Eachus, R.A.; Ham, T.S.; Kirby, J.; et al. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 2006, 440, 940–943. [Google Scholar] [CrossRef] [PubMed]
  2. Paddon, C.J.; Keasling, J.D. Semi-synthetic artemisinin: A model for the use of synthetic biology in pharmaceutical development. Nat. Rev. Microbiol. 2014, 12, 355–367. [Google Scholar] [CrossRef] [PubMed]
  3. Yan, X.; Fan, Y.; Wei, W.; Wang, P.; Liu, Q.; Wei, Y.; Zhang, L.; Zhao, G.; Yue, J.; Zhou, Z. Production of bioactive ginsenoside compound K in metabolically engineered yeast. Cell Res. 2014, 24, 770–773. [Google Scholar] [CrossRef] [PubMed]
  4. Yuan, W.; Jiang, C.; Wang, Q.; Fang, Y.; Wang, J.; Wang, M.; Xiao, H. Biosynthesis of mushroom-derived type II ganoderic acids by engineered yeast. Nat. Commun. 2022, 13, 7740. [Google Scholar] [CrossRef]
  5. Zhang, X.; Miao, Q.; Pan, C.; Yin, J.; Wang, L.; Qu, L.; Yin, Y.; Wei, Y. Research advances in probiotic fermentation of Chinese herbal medicines. Imeta 2023, 2, e93. [Google Scholar] [CrossRef]
  6. Choi, K.R.; Jang, W.D.; Yang, D.; Cho, J.S.; Park, D.; Lee, S.Y. Systems Metabolic Engineering Strategies: Integrating Systems and Synthetic Biology with Metabolic Engineering. Trends Biotechnol. 2019, 37, 817–837. [Google Scholar] [CrossRef]
  7. Ma, J.; Gu, Y.; Marsafari, M.; Xu, P. Synthetic biology, systems biology, and metabolic engineering of Yarrowia lipolytica toward a sustainable biorefinery platform. J. Ind. Microbiol. Biotechnol. 2020, 47, 845–862. [Google Scholar] [CrossRef]
  8. Chen, R.; Gao, J.; Yu, W.; Chen, X.; Zhai, X.; Chen, Y.; Zhang, L.; Zhou, Y.J. Engineering cofactor supply and recycling to drive phenolic acid biosynthesis in yeast. Nat. Chem. Biol. 2022, 18, 520–529. [Google Scholar] [CrossRef] [PubMed]
  9. Zhao, L.; Zhu, Y.; Jia, H.; Han, Y.; Zheng, X.; Wang, M.; Feng, W. From Plant to Yeast—Advances in Biosynthesis of Artemisinin. Molecules 2022, 27, 6888. [Google Scholar] [CrossRef]
  10. Zhang, X.; Tang, B.; Wen, S.; Wang, Y.; Pan, C.; Qu, L.; Yin, Y.; Wei, Y. Advancements in the Biotransformation and Biosynthesis of the Primary Active Flavonoids Derived from Epimedium. Molecules 2023, 28, 7173. [Google Scholar] [CrossRef]
  11. Xu, M.-L.; He, Y.-F.; Xie, L.; Qu, L.-B.; Xu, G.-R.; Cui, C.-X. Research Progress on Active Ingredients and Product Development of Lycium ruthenicum Murray. Molecules 2024, 29, 2269. [Google Scholar] [CrossRef]
  12. Drożdżyński, P.; Rutkowska, N.; Rodziewicz, M.; Marchut-Mikołajczyk, O. Bioactive Compounds Produced by Endophytic Bacteria and Their Plant Hosts—An Insight into the World of Chosen Herbaceous Ruderal Plants in Central Europe. Molecules 2024, 29, 4456. [Google Scholar] [CrossRef] [PubMed]
  13. Su, J.; Peng, T.; Bai, M.; Bai, H.; Li, H.; Pan, H.; He, H.; Liu, H.; Wu, H. Transcriptome and Metabolome Analyses Provide Insights into the Flavonoid Accumulation in Peels of Citrus reticulata ‘Chachi’. Molecules 2022, 27, 6476. [Google Scholar] [CrossRef] [PubMed]
  14. Ma, Q.; Zhang, S.; Yang, L.; Xie, Q.; Dai, H.; Yu, Z.; Zhao, Y. Lanostane Triterpenoids and Ergostane Steroids from Ganoderma luteomarginatum and Their Cytotoxicity. Molecules 2022, 27, 6989. [Google Scholar] [CrossRef] [PubMed]
  15. Alanazi, A.K.; Alqasmi, M.H.; Alrouji, M.; Kuriri, F.A.; Almuhanna, Y.; Joseph, B.; Asad, M. Antibacterial Activity of Syzygium aromaticum (Clove) Bud Oil and Its Interaction with Imipenem in Controlling Wound Infections in Rats Caused by Methicillin-Resistant Staphylococcus aureus. Molecules 2022, 27, 8551. [Google Scholar] [CrossRef]
  16. Sun, S.; Liu, X.; Zhao, D.; Zheng, L.; Han, X.; Tian, Y.; Feng, S. Discovery of the Active Compounds of the Ethyl Acetate Extract Site of Ardisia japonica (Thunb.) Blume for the Treatment of Acute Lung Injury. Molecules 2024, 29, 770. [Google Scholar] [CrossRef]
  17. Zhang, K.-X.; Zhu, Y.; Song, S.-X.; Bu, Q.-Y.; You, X.-Y.; Zou, H.; Zhao, G.-P. Ginsenoside Rb1, Compound K and 20(S)-Protopanaxadiol Attenuate High-Fat Diet-Induced Hyperlipidemia in Rats via Modulation of Gut Microbiota and Bile Acid Metabolism. Molecules 2024, 29, 1108. [Google Scholar] [CrossRef]
  18. Sun, T.; Zhao, Y.; Wang, J.; Kang, W.; Sun, X.; Sun, Y.; Chu, M.; Liu, Z.; Lu, F.; Li, M. Increasing 1,4-Diaminobutane Production in Escherichia coli by Optimization of Cofactor PLP and NADPH Synthesis. Molecules 2024, 29, 3094. [Google Scholar] [CrossRef]
  19. Caballero Cerbon, D.A.; Gebhard, L.; Dokuyucu, R.; Ertl, T.; Härtl, S.; Mazhar, A.; Weuster-Botz, D. Challenges and Advances in the Bioproduction of L-Cysteine. Molecules 2024, 29, 486. [Google Scholar] [CrossRef]
  20. Li, L.; Xiong, Y.; Wang, Y.; Wu, S.; Xiao, C.; Wang, S.; Cheng, S.; Cheng, H. Effect of Nano-Selenium on Nutritional Quality of Cowpea and Response of ABCC Transporter Family. Molecules 2023, 28, 1398. [Google Scholar] [CrossRef]
  21. Tu, Z.; Geng, A.; Xiang, Y.; Zayas-Garriga, A.; Guo, H.; Zhu, D.; Xie, R.; Sun, J. Lignin Degradation by Klebsiella aerogenes TL3 under Anaerobic Conditions. Molecules 2024, 29, 2177. [Google Scholar] [CrossRef] [PubMed]
  22. Bureau, J.A.; Oliva, M.E.; Dong, Y.; Ignea, C. Engineering yeast for the production of plant terpenoids using synthetic biology approaches. Nat. Prod. Rep. 2023, 40, 1822–1848. [Google Scholar] [CrossRef] [PubMed]
  23. Brooks, S.M.; Alper, H.S. Applications, challenges, and needs for employing synthetic biology beyond the lab. Nat. Commun. 2021, 12, 1390. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Wei, Y.; Qu, L.; Ji, X. Synthesis of Natural Products Using Engineered Plants and Microorganisms. Molecules 2024, 29, 5054. https://doi.org/10.3390/molecules29215054

AMA Style

Wei Y, Qu L, Ji X. Synthesis of Natural Products Using Engineered Plants and Microorganisms. Molecules. 2024; 29(21):5054. https://doi.org/10.3390/molecules29215054

Chicago/Turabian Style

Wei, Yongjun, Lingbo Qu, and Xiaojun Ji. 2024. "Synthesis of Natural Products Using Engineered Plants and Microorganisms" Molecules 29, no. 21: 5054. https://doi.org/10.3390/molecules29215054

APA Style

Wei, Y., Qu, L., & Ji, X. (2024). Synthesis of Natural Products Using Engineered Plants and Microorganisms. Molecules, 29(21), 5054. https://doi.org/10.3390/molecules29215054

Article Metrics

Back to TopTop